Application no. and date | 15755175.5 (espacenet) (Federated) (European Patent Register), 20150227 | Patent/reg. no. and date | DK/EP 3110446, 20211201 | Publication date | 20170104 | Priority no. and date | US 201461946407 P, 20140228 | EP pub. no. and date |
EP 3110446 20170104 | Effective date | | Applicant/owner | Allakos Inc., 975 Island Drive, Suite 201 Redwood City, CA 94065, US | Applicant ref. no. | V438382DK00 | Inventor | FALAHATI, Rustom, c/o Allakos Inc. 75 Shoreway Road Suite A
San Carlos, CA 94070, US, TOMASEVIC, Nenad, c/o Allakos Inc. 75 Shoreway Road Suite A
San Carlos, CA 94070, US, BEBBINGTON, Christopher, Robert, c/o Allakos Inc. 75 Shoreway Road Suite A
San Carlos, CA 94070, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 37/00 (2006.01) | Title | Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme | Int. application no. | US2015018188 | Int. publication no. | WO2015131155 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|